These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22221668)

  • 1. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.
    Shuch B; Bratslavsky G; Shih J; Vourganti S; Finley D; Castor B; Treat E; Linehan WM; Pantuck AJ; Said JW; Belldegrun AS
    BJU Int; 2012 Jun; 109(11):1600-6. PubMed ID: 22221668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma.
    Yan Y; Liu L; Zhou J; Li L; Li Y; Chen M; Wang L; He W; Guan X; Zu X; Qi L
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):345-52. PubMed ID: 25178995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
    Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
    Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
    Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microvascular invasion in localized renal cell carcinoma.
    Sevinç M; Kirkali Z; Yörükoğlu K; Mungan U; Sade M
    Eur Urol; 2000 Dec; 38(6):728-33. PubMed ID: 11111192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
    BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
    Keskin SK; Msaouel P; Hess KR; Yu KJ; Matin SF; Sircar K; Tamboli P; Jonasch E; Wood CG; Karam JA; Tannir NM
    J Urol; 2017 Sep; 198(3):530-537. PubMed ID: 28411072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology.
    Salgia NJ; Aubrecht WM; Wang L; Ram B; Wasik BJ; Khan A; Attwood K; Daza J; Long MD; Eng KH; Xu B; Muhitch JB; Kauffman EC
    Eur Urol Oncol; 2024 Oct; 7(5):973-977. PubMed ID: 38480032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic venous invasion: a prognostic factor in renal cell carcinoma.
    Lang H; Lindner V; Saussine C; Havel D; Faure F; Jacqmin D
    Eur Urol; 2000 Nov; 38(5):600-5. PubMed ID: 11096243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
    Merrill MM; Wood CG; Tannir NM; Slack RS; Babaian KN; Jonasch E; Pagliaro LC; Compton Z; Tamboli P; Sircar K; Pisters LL; Matin SF; Karam JA
    Urol Oncol; 2015 Apr; 33(4):166.e21-9. PubMed ID: 25700975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic venous invasion is associated with disease free and cancer free survival in renal cell carcinoma.
    Sanli O; Zorba OU; Erdem S; Tezer M; Kilicar-Slan I; Esen T; Tunc M
    Minerva Urol Nefrol; 2010 Dec; 62(4):347-53. PubMed ID: 20944535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
    J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.